Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq Composite, Dow 30, Nikkei 225, DAX Index, FTSE 100
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
Here is a great opportunity to go long on NVCR. At Three Percent Trades we have a price target of $90.00 / share, which is a potential upside of 14.1% from the current level. We use a combination of fundamentals & technical analysis to trade high probability set-ups, and believe this is a great opportunity to take advantage.
Analysis based on rising above or falling below trend lines (green bullish) (red bearish)
Strike price $85, Exp-03/20/20 Entry price- $12.10 Target: $25 Position Size: 4%/100%
Could see a nice break of the descending channel and pump into earnings. RSI broke its track upward. Entered 44.85
1. Not up three days in a row 2. Linear move up prior to consolidation 3. Young Trend 4. No breakouts or breakdowns during consolidation phase 5. Clean and low volatility consolidation ***see roboticinvesting.com for more details on Momentum Surge
1. Not up three days in a row 2. Linear move up prior to consolidation 3. Young Trend 4. No breakouts or breakdowns during consolidation phase 5. Clean and low volatility consolidation ***see roboticinvesting.com for more details on Momentum Surge
NVCR - Novocure - oversold on the weekly and oversold on the daily. Could setup for a nice bounce back here!
NVCR: novocure ltd ord sh 2018-04-17 07:30:06 Detected possible positive results in drug trial
NVCR looks like it will have a promising next couple months if it stays consistent with the channel as it just bounced of the support line today. Bottom support has now been tested 3x. Should be promising.
Great chart pattern with clearance of some key fib levels, positive momentum, and large volume breakout, off of a 6-7 month trading range. Bought some outright shares on Friday, as the options are thinly traded. Happy Trading Lindosskier
Catalyst is JPM healthcare conference presentation 1/10/17. Good volume and made all time highs. Didn't move intraday but it still seems like a confirmed brakeout. 6 month consolidation could get explosive.
Momentary uptrend. Long term investment. Trail 3 is ongoing 2 years before market acceptance in my opinion.